First line weekly carboplatin and paclitaxel versus every 3 weeks carboplatin/paclitaxel in patients with ovarian cancer: phase III multicentre trial
Trial Number
NCT00660842 (ClinicalTrials.gov ID)Contact Person
Status
Completed
Disease Site
Ovarian
Lead Cooperative Group
Participating Groups
MaNGO
GINECO